BR0016093A - Composto, processo para produzir o mesmo, uso de um composto, e, composição farmacêutica - Google Patents
Composto, processo para produzir o mesmo, uso de um composto, e, composição farmacêuticaInfo
- Publication number
- BR0016093A BR0016093A BR0016093-8A BR0016093A BR0016093A BR 0016093 A BR0016093 A BR 0016093A BR 0016093 A BR0016093 A BR 0016093A BR 0016093 A BR0016093 A BR 0016093A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- same
- unsubstituted
- substituted
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000002947 alkylene group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- QDGSQQMUZONPER-UHFFFAOYSA-N benzo[a]phenazine-11-carboxamide Chemical group C1=CC=CC2=C(N=C3C(C(=O)N)=CC=CC3=N3)C3=CC=C21 QDGSQQMUZONPER-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical compound C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005553 heteroaryloxy group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSTO, PROCESSO PARA PRODUZIR O MESMO, USO DE UM COMPOSTO, E, COMPOSIçãO FARMACêUTICA". Um composto que é um derivado de benzo[a]fenazina-11-carboxamida da fórmula (I) em que cada um de R^ 1^ a R^ 4^, que são os mesmos ou diferentes, é selecionado de hidrogênio, halógeno, hidroxila, alcóxi C~ 1~-C~ 6~ que é não substituído ou substituído, heteroarilóxi, alquila C~ 1~-C~ 6~ que é não substituído ou substituído, nitro, ciano, azido, amidoxima, CO~ 2~R^ 10^, CON(R^ 12^)~ 2~, OCON(R^ 2^), SR^ 10^, SOR^ 11^, SO~ 2~(R^ 11^), SO~ 2~N(R^ 12^)~ 2~, N(R^ 12^)~ 2~, NR^ 10^SO~ 2~R^ 11^, N(SO~ 2~R^ 11^)~ 2~NR^ 10^(CH~ 2~)~ n~CN, NR^ 10^COR^ 11^, OCOR^ 11^ ou COR^ 10^; cada um de R^ 5^ a R^ 7^, que são os mesmos ou diferentes, é selecionado de hidrogênio, halógeno, hidróxi, alcóxi C~ 1~-C~ 6~, alquila C~ 1~-C~ 6~, SR^ 10^ e N(R^ 12^)~ 2~; Q é alquileno C~ 1~-C~ 6~ que é não substituído ou substituído por (i) alquila C~ 1~-C~ 6~ que é não substituído ou substituído, (ii) hidróxi, contanto que o grupo hidróxi não seja <244> a cada um dos átomos N adjacentes a Q na fórmula (I), (iii) CO~ 2~R^ 10^, ou (iv) CON(R^ 12^); R^ 8^ e R^ 9^, que são os mesmos ou diferentes, são cada um hidrogênio ou alquila C~ 1~-C~ 6~, ou R~ 8~ e R~ 9~ juntos com o átomo de nitrogênio ao qual estão ligados formam um anel heterocíclico contendo N, de 5 ou 6 membros, saturado que pode incluir um heteroátomo adicional selecionado de O, N e S, ou um de R^ 8^ e R^ 9^ é uma cadeia de alquileno opcionalmente interrompida por O, N ou S, que estão ligados a um átomo de carbono na cadeia de alquileno representada por Q para completar um anel heterocíclico contendo N, de 5 ou 6 membros,
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9928542.1A GB9928542D0 (en) | 1999-12-02 | 1999-12-02 | Pharmaceutical compounds |
| PCT/GB2000/004609 WO2001046157A1 (en) | 1999-12-02 | 2000-12-01 | Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0016093A true BR0016093A (pt) | 2002-08-20 |
Family
ID=10865607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0016093-8A BR0016093A (pt) | 1999-12-02 | 2000-12-01 | Composto, processo para produzir o mesmo, uso de um composto, e, composição farmacêutica |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1240148A1 (pt) |
| JP (1) | JP2003518103A (pt) |
| KR (1) | KR100767613B1 (pt) |
| CN (1) | CN1304380C (pt) |
| AU (1) | AU784397B2 (pt) |
| BR (1) | BR0016093A (pt) |
| CA (1) | CA2392873A1 (pt) |
| GB (2) | GB9928542D0 (pt) |
| HK (1) | HK1046133B (pt) |
| HU (1) | HUP0300392A3 (pt) |
| MX (1) | MXPA02005476A (pt) |
| MY (1) | MY136029A (pt) |
| PL (1) | PL356482A1 (pt) |
| TW (1) | TWI280242B (pt) |
| WO (1) | WO2001046157A1 (pt) |
| ZA (1) | ZA200204296B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2433071A (en) * | 2005-12-05 | 2007-06-13 | Kontrakt Technology Ltd | Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell |
| CN102898388B (zh) * | 2012-09-26 | 2014-12-03 | 浙江工业大学 | 一种合成取代苯并[α]吩嗪类化合物的方法 |
| CN103360329B (zh) * | 2013-07-18 | 2015-11-18 | 中国科学院南海海洋研究所 | 一类吩嗪化合物及其在制备抗肿瘤药物中的应用 |
| CN106554321B (zh) * | 2015-09-25 | 2019-05-28 | 陆源 | 一种吩嗪类物质、其制备方法及其应用 |
| CN113461623A (zh) * | 2021-07-14 | 2021-10-01 | 长江大学 | 一种抗病毒化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE195869T1 (de) * | 1992-05-28 | 2000-09-15 | Xenova Ltd | Acridin carboxamide zur behandlung von krebs |
| US5696131A (en) * | 1993-01-22 | 1997-12-09 | Xenova Limited | Treatment of cancers |
| TR199900636T2 (xx) * | 1996-09-23 | 1999-10-21 | Rutgers, The State University Of New Jersey | Anti-t�m�r ajanlar� olarak ikameli/katk�l� heterosayk�llar. |
| WO1998045272A1 (en) * | 1997-04-07 | 1998-10-15 | Latrobe University | Topoisomerase inhibitors |
-
1999
- 1999-12-02 GB GBGB9928542.1A patent/GB9928542D0/en not_active Ceased
-
2000
- 2000-12-01 WO PCT/GB2000/004609 patent/WO2001046157A1/en active Application Filing
- 2000-12-01 HU HU0300392A patent/HUP0300392A3/hu unknown
- 2000-12-01 EP EP00979799A patent/EP1240148A1/en not_active Withdrawn
- 2000-12-01 CN CNB008187096A patent/CN1304380C/zh not_active Expired - Fee Related
- 2000-12-01 MY MYPI20005670A patent/MY136029A/en unknown
- 2000-12-01 KR KR1020027007033A patent/KR100767613B1/ko not_active IP Right Cessation
- 2000-12-01 AU AU17184/01A patent/AU784397B2/en not_active Ceased
- 2000-12-01 CA CA002392873A patent/CA2392873A1/en not_active Abandoned
- 2000-12-01 GB GB0215275A patent/GB2373499B/en not_active Expired - Fee Related
- 2000-12-01 JP JP2001547068A patent/JP2003518103A/ja active Pending
- 2000-12-01 MX MXPA02005476A patent/MXPA02005476A/es not_active Application Discontinuation
- 2000-12-01 BR BR0016093-8A patent/BR0016093A/pt not_active IP Right Cessation
- 2000-12-01 PL PL00356482A patent/PL356482A1/xx not_active Application Discontinuation
- 2000-12-02 TW TW089125715A patent/TWI280242B/zh not_active IP Right Cessation
-
2002
- 2002-05-29 ZA ZA200204296A patent/ZA200204296B/en unknown
- 2002-10-10 HK HK02107392.7A patent/HK1046133B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2373499A (en) | 2002-09-25 |
| GB2373499B (en) | 2004-11-17 |
| KR20020070305A (ko) | 2002-09-05 |
| HUP0300392A2 (hu) | 2003-07-28 |
| CA2392873A1 (en) | 2001-06-28 |
| TWI280242B (en) | 2007-05-01 |
| HK1046133B (zh) | 2005-04-15 |
| CN1433406A (zh) | 2003-07-30 |
| CN1304380C (zh) | 2007-03-14 |
| KR100767613B1 (ko) | 2007-10-19 |
| JP2003518103A (ja) | 2003-06-03 |
| MY136029A (en) | 2008-07-31 |
| AU1718401A (en) | 2001-07-03 |
| GB9928542D0 (en) | 2000-02-02 |
| HK1046133A1 (en) | 2002-12-27 |
| GB0215275D0 (en) | 2002-08-14 |
| EP1240148A1 (en) | 2002-09-18 |
| ZA200204296B (en) | 2003-05-29 |
| MXPA02005476A (es) | 2003-09-22 |
| WO2001046157A1 (en) | 2001-06-28 |
| HUP0300392A3 (en) | 2003-09-29 |
| AU784397B2 (en) | 2006-03-23 |
| PL356482A1 (en) | 2004-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR860004060A (ko) | 티에닐 축합 피라졸 유도체의 제조방법 | |
| PT96897A (pt) | Processo para a preparacao de novos compostos aril-e heteroariletilenicos e de composicoes farmaceuticas que os contem | |
| CO5261551A1 (es) | Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas | |
| BR0110404A (pt) | Derivados de imidazopirimidina e derivados de triazolpirimidina | |
| MX9204008A (es) | Derivados de metilen-oxindol y proceso para su preparacion. | |
| BR9806413A (pt) | Composto e uso do mesmo | |
| UY28149A1 (es) | Compuestos quimicos | |
| DK7280A (da) | Fremgangsmaade til fremstilling af (piperidinylalkyl) quinazolin-derivater | |
| KR890000489A (ko) | 6 환 화합물 | |
| BR1101017A (pt) | Distamicina a análoga; processo para a apresentação de um composto; composição farmacêutica contendo um composto; e uso de um composto | |
| PT93552A (pt) | Processo para a preparacao de derivados de pirrol acriloil-substituidos e de composicoes farmaceuticas que os contem | |
| ES2179005T3 (es) | Compuesto de cromeno. | |
| ES2179489T3 (es) | Uso de tienopirimidinas como fungicidas. | |
| ES2061580T3 (es) | Compuestos de 3,7-diazabiciclo(3,3,1)nonano, asi como procedimiento para su preparacion y medicamentos que contienen estos compuestos. | |
| BR0016093A (pt) | Composto, processo para produzir o mesmo, uso de um composto, e, composição farmacêutica | |
| CO5040004A1 (es) | 2-4-diamino-1,3,5-triazinas, su preparacion y empleo como herbicidas y fitorreguladores | |
| AR018632A1 (es) | Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion. | |
| BR0116406A (pt) | Composição para revestimento e substrato revestido com boa estabilidade ao calor de cor | |
| KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
| KR880009959A (ko) | 방향족 아민 유도체 | |
| CO5160255A1 (es) | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN | |
| BR9800844A (pt) | Método para a preparação de derivados de alfa-bromo lactama. | |
| HUP0203603A2 (hu) | Új IL-8 receptor antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| ATE7025T1 (de) | 4-carbamoylimidazol-5-ol-derivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| FR2479219B1 (pt) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |